Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,220 | 300 | 98.1% |
| Education | $99.00 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,084 | 67 | $0 (2022) |
| PFIZER INC. | $839.63 | 41 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $653.32 | 35 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $257.96 | 18 | $0 (2022) |
| Merck Sharp & Dohme LLC | $257.88 | 19 | $0 (2022) |
| GlaxoSmithKline, LLC. | $253.66 | 18 | $0 (2021) |
| Novo Nordisk Inc | $249.09 | 14 | $0 (2022) |
| Amgen Inc. | $234.25 | 13 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $214.08 | 8 | $0 (2021) |
| ABBVIE INC. | $207.02 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $366.54 | 20 | SANOFI-AVENTIS U.S. LLC ($50.90) |
| 2021 | $1,141 | 63 | Nestle HealthCare Nutrition Inc. ($189.57) |
| 2020 | $659.11 | 34 | AstraZeneca Pharmaceuticals LP ($165.14) |
| 2019 | $617.49 | 40 | AstraZeneca Pharmaceuticals LP ($222.43) |
| 2018 | $1,131 | 64 | PFIZER INC. ($287.05) |
| 2017 | $1,405 | 80 | PFIZER INC. ($348.14) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Obesity | ||||||
| 04/29/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Respiratory | ||||||
| 04/22/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/19/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Respiratory | ||||||
| 04/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: VACCINE | ||||||
| 04/08/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: VACCINES | ||||||
| 04/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Gastroenterology | ||||||
| 04/01/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/29/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Respiratory | ||||||
| 03/18/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Cardiology | ||||||
| 03/15/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 03/11/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: PRIMARY CARE | ||||||
| 03/04/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: PRIMARY CARE | ||||||
| 02/11/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Diabetes | ||||||
| 02/08/2022 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Respiratory | ||||||
| 02/04/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: HIV | ||||||
| 01/21/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/28/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: HIV | ||||||
| 12/10/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: VACCINE | ||||||
| 12/07/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/19/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 238 | 249 | $47,535 | $7,332 |
| 2021 | 9 | 741 | 907 | $171,920 | $55,246 |
| 2020 | 13 | 872 | 1,030 | $168,030 | $54,413 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 83 | $19,920 | $2,798 | 14.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 40 | $13,600 | $1,636 | 12.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $9,270 | $1,492 | 16.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 41 | 41 | $1,640 | $789.60 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $2,380 | $335.46 | 14.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 28 | 29 | $725.00 | $281.19 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 128 | 128 | $28,200 | $17,405 | 61.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 151 | 260 | $62,060 | $14,497 | 23.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 147 | 149 | $50,380 | $11,891 | 23.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 20 | 20 | $6,400 | $3,491 | 54.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 79 | $13,300 | $3,014 | 22.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 132 | 132 | $5,280 | $2,561 | 48.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 44 | 45 | $2,250 | $797.45 | 35.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 49 | 82 | $2,050 | $796.22 | 38.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 12 | $2,000 | $792.94 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 127 | 127 | $27,940 | $15,218 | 54.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 191 | 288 | $60,470 | $13,789 | 22.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 139 | 139 | $37,530 | $9,215 | 24.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 101 | $14,170 | $2,905 | 20.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 16 | 16 | $5,120 | $2,858 | 55.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 130 | 130 | $5,200 | $2,451 | 47.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 11 | 12 | $5,400 | $2,441 | 45.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 36 | 42 | $3,120 | $1,934 | 62.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 63 | 66 | $3,300 | $1,160 | 35.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 14 | 15 | $1,670 | $962.65 | 57.6% |
About Dr. Robert Mathieu, M.D
Dr. Robert Mathieu, M.D is a Internal Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659377315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mathieu, M.D has received a total of $5,319 in payments from pharmaceutical and medical device companies, with $366.54 received in 2022. These payments were reported across 301 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,220).
As a Medicare-enrolled provider, Mathieu has provided services to 1,851 Medicare beneficiaries, totaling 2,186 services with total Medicare billing of $116,991. Data is available for 3 years (2020–2022), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Providence, RI
- Active Since 06/27/2005
- Last Updated 10/19/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659377315
Products in Payments
- ELIQUIS (Drug) $634.13
- SYMBICORT (Drug) $443.96
- FARXIGA (Drug) $433.27
- TOUJEO (Drug) $231.66
- ZENPEP (Drug) $214.08
- SOLIQUA (Drug) $172.67
- TRELEGY ELLIPTA (Drug) $143.19
- PREZCOBIX (Drug) $132.85
- CHANTIX (Drug) $126.62
- Saxenda (Drug) $122.97
- NURTEC ODT (Drug) $122.23
- AirDuo Digihaler (Drug) $110.76
- BREZTRI (Drug) $100.93
- Repatha (Biological) $91.75
- Synthroid (Drug) $91.29
- JANUVIA (Drug) $90.94
- SOLIQUA 100/33 (Biological) $85.46
- Prolia (Biological) $77.22
- TOUJEO (Biological) $74.13
- Ozempic (Drug) $72.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Providence
Randall Ingham, M.d, M.D
Internal Medicine — Payments: $154,470
Farah Moustafa, Md, MD
Internal Medicine — Payments: $50,984
Monica Dhakar, M.d, M.D
Internal Medicine — Payments: $47,405
Hajra Awwab, Md, MD
Internal Medicine — Payments: $41,418
Richard Ruggieri, M.d, M.D
Internal Medicine — Payments: $36,352
Dr. Peter Barth, M.d, M.D
Internal Medicine — Payments: $29,192